StockData
IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

INVO Fertility, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.60+0.04 (+7.78%)

Close on Oct 19, 2026

Market cap
$1.56M
P/E (TTM)
–
Dividend yield
–

INVO Fertility, Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018% of revenueYoY
Fertility Clinic Services [Member]$6.72M$6.45M$2.86M–––––98.2%+4.2%
INVOcell Device [Member]$147.19K$110.57K$158.00K–––––2.2%+33.1%
Other Operating Segment [Member]–-$29.00K––––––––

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018% of revenueYoY
Revenue From External Customers [Member]$6.84M$6.53M$3.02M–––––100.0%+4.7%
Clinic Revenue [Member]$6.72M$6.45M$2.86M$614.85K$43.75K–––98.2%+4.2%
Product [Member]$120.19K$81.57K$158.00K$207.34K$544.94K–––1.8%+47.4%
Inter Segment Revenue [Member]$27.00K$29.00K––––––0.4%-6.9%
Domestic Physicians [Member]–––––$323.00K$765.93K$494.38K––
Domestic Licensing & Distribution Fee [Member]–––––$714.29K$714.29K$0––
Product Revenue [Member]––––$544.94K$323.00K$765.93K$494.38K––
License [Member]––––$3.57M$714.29K$714.29K$0––
License Revenue [Member]––––$3.57M$714.29K––––

By region

From the segment and revenue-disaggregation notes of INVO Fertility's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.